Yuyang Song completed his Bachelor of Science and Master of Biomedical Science at the University of Melbourne. Currently enrolled as a PhD student in the Molecular Imaging and Theranostics laboratory, Yuyang is conducting medical research under the supervision of A/Prof Xiaowei Wang, Dr Cuong Viet Pham and Prof Karlheinz Peter. The focus of his research lies in the development of novel drug constructs and treatments for cardiovascular diseases (CVDs).

Yuyang's PhD projects aim to address existing side effects of current treatments for CVD through various approaches, including engineering recombinant antibody-drug fusions for targeted therapy, utilising extracellular vesicles as drug nanocarriers, and developing next-generation mRNA for personalised medicine. The hypothesis posits that these constructs will offer complication-free protection/treatment for CVD patients. By breaking the fatal link between therapeutic effects and side effects, Yuyang believes these drugs can enhance patient survival rates and improve the quality of life for millions affected.

As an extension of his academic pursuits, Yuyang is currently a student member of various professional organisations, including the Australian Society of Molecular Imaging, the Australian Cardiovascular Alliance, and the Australia and New Zealand Society for Extracellular Vesicles.